Cargando…
Design of Phase 3 Studies Evaluating Vixotrigine for Treatment of Trigeminal Neuralgia
PURPOSE: Vixotrigine (BIIB074) is a voltage- and use-dependent sodium channel blocker. These studies will evaluate the efficacy and safety of vixotrigine in treating pain experienced by patients with trigeminal neuralgia (TN) using enriched enrollment randomized withdrawal trial designs. PATIENTS AN...
Autores principales: | Kotecha, Mona, Cheshire, William P, Finnigan, Helen, Giblin, Kathryn, Naik, Himanshu, Palmer, Joanne, Tate, Simon, Zakrzewska, Joanna M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335847/ https://www.ncbi.nlm.nih.gov/pubmed/32669869 http://dx.doi.org/10.2147/JPR.S247182 |
Ejemplares similares
-
Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
por: Naik, Himanshu, et al.
Publicado: (2020) -
Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia
por: Zakrzewska, Joanna M, et al.
Publicado: (2013) -
Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal study
por: Faber, Catharina G., et al.
Publicado: (2023) -
Evaluation of the Potential Pharmacokinetic Interactions Between Vixotrigine and an Oral Contraceptive
por: Zhao, Yuan, et al.
Publicado: (2020) -
Burden of illness of trigeminal neuralgia among patients managed in a specialist center in England
por: O’Callaghan, Lasair, et al.
Publicado: (2020)